161 related articles for article (PubMed ID: 21499808)
1. Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.
Abdollah F; Sun M; Thuret R; Schmitges J; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Ann Surg Oncol; 2011 Oct; 18(10):2988-96. PubMed ID: 21499808
[TBL] [Abstract][Full Text] [Related]
2. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
3. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
Zini L; Capitanio U; Perrotte P; Jeldres C; Shariat SF; Arjane P; Widmer H; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2009 Feb; 73(2):342-6. PubMed ID: 19041122
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.
Sun M; Abdollah F; Schmitges J; Bianchi M; Tian Z; Shariat SF; Zorn K; Pharand D; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2012 Jun; 109(12):1807-12. PubMed ID: 21951647
[TBL] [Abstract][Full Text] [Related]
5. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series.
Sun M; Abdollah F; Shariat SF; Schmitges J; Trinh QD; Tian Z; Jeldres C; Abdo A; Bianchi M; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur J Surg Oncol; 2012 Jan; 38(1):80-7. PubMed ID: 21996370
[TBL] [Abstract][Full Text] [Related]
6. In-hospital mortality and failure to rescue after cytoreductive nephrectomy.
Trinh QD; Bianchi M; Hansen J; Tian Z; Abdollah F; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI; Sun M
Eur Urol; 2013 Jun; 63(6):1107-14. PubMed ID: 22981674
[TBL] [Abstract][Full Text] [Related]
7. A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Jeldres C; Baillargeon-Gagne S; Liberman D; Isbarn H; Capitanio U; Shariat SF; Sun M; Lughezzani G; Perrotte P; Montorsi F; Graefen M; Karakiewicz PI
Urology; 2009 Oct; 74(4):837-41. PubMed ID: 19616828
[TBL] [Abstract][Full Text] [Related]
8. The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer.
Kim SP; Leibovich BC; Shah ND; Weight CJ; Borah BJ; Han LC; Boorjian SA; Thompson RH
BJU Int; 2013 Apr; 111(4):580-8. PubMed ID: 22564425
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
[TBL] [Abstract][Full Text] [Related]
12. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
Mazzone E; Nazzani S; Preisser F; Tian Z; Marchioni M; Bandini M; Capitanio U; Kapoor A; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; I Karakiewicz P
Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
[TBL] [Abstract][Full Text] [Related]
13. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
[TBL] [Abstract][Full Text] [Related]
15. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
Zini L; Perrotte P; Jeldres C; Capitanio U; Pharand D; Arjane P; Lapointe S; Montorsi F; Patard JJ; Karakiewicz PI
BJU Int; 2008 Dec; 102(11):1610-4. PubMed ID: 18710442
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207
[TBL] [Abstract][Full Text] [Related]
17. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
18. Operative mortality after nephrectomy for renal cell carcinoma.
Thoroddsen A; Gudbjartsson T; Jonsson E; Gislason T; Einarsson GV
Scand J Urol Nephrol; 2003; 37(6):507-11. PubMed ID: 14675926
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
Bigot P; Lughezzani G; Karakiewicz P; Perrotte P; Rioux-Leclercq N; Catros-Quemener V; Bouet F; Moulinoux JP; Cipolla B; Patard JJ
J Urol; 2010 Feb; 183(2):486-91. PubMed ID: 20006872
[TBL] [Abstract][Full Text] [Related]
20. Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy.
Sun M; Bianchi M; Trinh QD; Abdollah F; Schmitges J; Jeldres C; Shariat SF; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2012 Feb; 187(2):405-10. PubMed ID: 22177151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
